2018
DOI: 10.1016/j.stem.2018.05.016
|View full text |Cite
|
Sign up to set email alerts
|

Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges

Abstract: Restoration of insulin independence and normoglycemia has been the overarching goal in diabetes research and therapy. While whole-organ and islet transplantation have become gold-standard procedures in achieving glucose control in diabetic patients, the profound lack of suitable donor tissues severely hampers the broad application of these therapies. Here, we describe current efforts aimed at generating a sustainable source of functional human stem cell-derived insulin-producing islet cells for cell transplant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
158
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 197 publications
(161 citation statements)
references
References 142 publications
2
158
0
1
Order By: Relevance
“…Generating functional stem-cell-derived tissues is a major goal of regenerative medicine, yet current strategies yield products that often fail to recapitulate endogenous cellular function (Sances et al, 2016;Sneddon et al, 2018;Yang et al, 2014). Our group and others advanced methods to differentiate human pluripotent stem cells (hPSCs) into pancreatic islet cells Rezania et al, 2014;Russ et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Generating functional stem-cell-derived tissues is a major goal of regenerative medicine, yet current strategies yield products that often fail to recapitulate endogenous cellular function (Sances et al, 2016;Sneddon et al, 2018;Yang et al, 2014). Our group and others advanced methods to differentiate human pluripotent stem cells (hPSCs) into pancreatic islet cells Rezania et al, 2014;Russ et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Intensive work on the biology of the pancreas has focused on developing better treatments for devastating pancreatic diseases, including diabetes mellitus, pancreatitis, and pancreatic cancer. Notably, elucidation of the embryonic development of the pancreas, particularly the mechanisms underlying endocrine cell specification, has provided important guidelines for deriving pancreatic cells from human pluripotent stem cells for therapeutic purposes (Sneddon et al , ).…”
Section: Single‐cell Transcriptomic Analyses Of Pancreatic Organogenementioning
confidence: 99%
“…The use of human primary tissues to address such questions is limited by inter-individual heterogeneity, unpredictable and restricted access to tissue from key developmental stages, and challenges implementing high-throughput molecular approaches. Likewise, reconstitution of islet development from stem cell sources or fetal human cell lines remains imperfect 8 , thereby limiting interpretation of developmental studies in those systems.…”
mentioning
confidence: 99%